top of page
Joint Action on Rare Cancers
Work Package 6
Quality Evaluation of Clinical Practice Guidelines (CPGs) on rare cancers
Topic: Central Nervous System tumours
CPGs graded Strong
Weller M et al. (2014). S2k Guidelines for Diagnostics and Therapy in Neurology: Gliomas. AWMF registration number: 030/099. Published by the Guidelines Commission of the German Society of Neurology. Update 2017;
https://www.dgn.org/images/red_leitlinien/LL_2014/PDFs_Download/030099_DGN_LL_Gliome_final.pdf
Hofer S, Bullinger L, Dierlamm J, Grosu AL. (2017). Leitlinie Gliome im Erwachsenenalter (ICD-10 C71); Update 2019.
https://www.onkopedia.com/de/onkopedia/guidelines/gliome-im-erwachsenenalter/@@view/pdf/index.pdf
Perrot E, Martin E, Fournel P (2018) on behalf of the editing committee of Auvergne-Rhône-Alpes Guidelines in Thoracic Oncology. [Guidelines on Brain Metastasis of Lung Cancers: 2019 Update]. ARISTOT; 2019 [French]. ISBN 978-2-490858-05-7. Available from http://espacecancer.sante-ra.fr/Pages/referentiels.aspx and from www.lecancer.fr; http://reseau-cancerologie-grand-est.fr/wp-content/uploads/2019/03/M_SNC_2019_VDEF.pdf
NICE guideline: Brain tumours (primary) and brain metastases in adults (NG99). Published: 11 July 2018;
https://www.nice.org.uk/guidance/ng99/resources/brain-tumours-primary-and-brain-metastases-in-adults-pdf-1837763558341
Stupp, R., et al. (2014). "High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up." Annals of Oncology 25(suppl_3): iii93-iii101. https://academic.oup.com/annonc/article-pdf/25/suppl_3/iii93/6674203/mdu050.pdf
Le Rhun, E., et al. (2017). "EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours." Annals of Oncology 28(suppl_4): iv84-iv99.
https://academic.oup.com/annonc/article-pdf/28/suppl_4/iv84/18564046/mdx221.pdf
Weller, M., et al. (2017). "European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas." The Lancet Oncology 18(6): e315-e329. DOI: https://doi.org/10.1016/S1470-2045(17)30194-8; https://www.zora.uzh.ch/id/eprint/141088/1/LO_EANO_2016-9-11.pdf
Raverot G, Burman P et al. (2018). European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. European journal of endocrinology 178(1). p.1-24; DOI: https://doi.org/10.1530/EJE-17-0796;
https://eje.bioscientifica.com/downloadpdf/journals/eje/178/1/EJE-17-0796.xml
Rudà, R., et al. (2017). "EANO guidelines for the diagnosis and treatment of ependymal tumors." Neuro-Oncology 20(4): 445-456.
https://academic.oup.com/neuro-oncology/article-pdf/20/4/445/24688019/nox166.pdf
Hoang-Xuan K, Bessell E, Weller M et al. (2015). Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncology, 16(7):e322-332.
https://www.zora.uzh.ch/id/eprint/114449/1/THELANCETONCOLOGY-D-14-01617R21.pdf
CPGs graded Moderate
Soffietti, R., et al. (2017). "Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)." Neuro-Oncology 19(2): 162-174; doi:10.1093/neuonc/now241.
https://doi.org/10.1093/neuonc/now241; https://academic.oup.com/neuro-oncology/article-pdf/19/2/162/17682210/now241.pdf
Lancashire and South Cumbria Cancer Network: Management Guidelines for Malignant Brain Tumours. (Version 2, Dated October 2015) review date October 2017;
https://www.gmecscn.nhs.uk/attachments/article/276/LSCCN%20Brain%20Tumour%20GUIDELINES%20Final%20(2).pdf
London Cancer Alliance 2014: Brain/CNS Cancer Clinical Guidelines;
http://www.londoncanceralliance.nhs.uk/media/74514/LCA_BCNS_Guidelines_FINAL.pdf
Burcheri et al. (2013). Lymphomes Cérébraux Primitifs (Recommandations nationales de bonnes pratiques)/ Primary central nervous system lymphomas (PCNSL). Référentiel régional Onco-LR, Comité Onco-Hématologie.
http://www.oncolr.org/upload/Espace_professionnel/Recommandations_regionales/Validation_lymphomes_cerebraux.pdf
Schlegel U, Illerhaus G et al. (2015). Primäre ZNS-Lymphome (PZNSL). S2k-Leitlinien für Diagnostik und Therapie in der Neurologie (AWMF-Registernummer: 030/059).
https://www.awmf.org/uploads/tx_szleitlinien/030-059l_Prim%C3%A4re_ZNS_Lymphome_PZNSL_2015-06-abgelaufen.pdf
Rutkowsk S, Trollmann R et al. (2016). S1-Leitlinie 025/022: Leitsymptome und Diagnostik der ZNS-Tumoren im Kindes- und Jugendalter (Tumors of the Central Nervous System in Children and Adolescents).
https://www.awmf.org/uploads/tx_szleitlinien/025-022l_S1_ZNS-Tumoren_Kinder_Jugendliche_2016-09.pdf
Work Package 6
bottom of page